{"id":2772,"date":"2017-05-16T16:42:48","date_gmt":"2017-05-16T16:42:48","guid":{"rendered":"http:\/\/www.irlab.se\/irlab-beslut-vid-arsstamma-2017\/"},"modified":"2017-05-16T16:42:48","modified_gmt":"2017-05-16T16:42:48","slug":"irlab-beslut-vid-arsstamma-2017","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/","title":{"rendered":"IRLAB &#8211; Beslut vid \u00e5rsst\u00e4mma 2017"},"content":{"rendered":"<p><strong>Disposition av bolagets resultat<\/strong><\/p>\n<p>Den av styrelsen f&ouml;reslagna dispositionen av bolagets resultat godk&auml;ndes av st&auml;mman. Detta inneb&auml;r att det till &aring;rsst&auml;mmans f&ouml;rfogande st&aring;ende beloppet, uppg&aring;ende till 174&nbsp;179&nbsp;352 kr, i sin helhet skall &ouml;verf&ouml;ras i ny r&auml;kning och att ingen utdelning skulle l&auml;mnas f&ouml;r det g&aring;ngna r&auml;kenskaps&aring;ret.<\/p>\n<p><strong>Ansvarsfrihet &aring;t styrelseledam&ouml;terna och verkst&auml;llande direkt&ouml;ren<\/strong><\/p>\n<p>&Aring;rsst&auml;mman beslutade att bevilja styrelseledam&ouml;terna och verkst&auml;llande direkt&ouml;ren ansvarsfrihet f&ouml;r r&auml;kenskaps&aring;ret 2016.<\/p>\n<p><strong>Arvode<\/strong><\/p>\n<p>Arvode till styrelsen beslutades utg&aring; med 200&nbsp;000 kr till styrelsens ordf&ouml;rande och 80&nbsp;000 kr till envar av &ouml;vriga ledam&ouml;ter. Arvode till revisorn beslutades utg&aring; enligt l&ouml;pande r&auml;kning.<\/p>\n<p><strong>Val av styrelseledam&ouml;ter och revisor<\/strong><\/p>\n<p>Det beslutades att styrelsen ska best&aring; av sju ledam&ouml;ter. Till styrelseledam&ouml;ter nyvaldes Lars Adlersson, Gunnar Olsson och Hans-Olov Olsson och omvaldes Eva Lindgren, Rein Piir, Jacob Testor och Anders Vedin. Till styrelsens ordf&ouml;rande omvaldes Anders Vedin. Hans-Peter Ostler hade avb&ouml;jt omval. Som revisor omvaldes revisionsbolaget &Ouml;hrlings PricewaterhouseCoopers AB med huvudansvarig revisor Johan Rippe.<\/p>\n<p><strong>Riktlinjer f&ouml;r ers&auml;ttning till ledande befattningshavare<\/strong><\/p>\n<p>I enlighet med styrelsens f&ouml;rslag beslutade st&auml;mman om riktlinjer f&ouml;r ers&auml;ttning till ledande befattningshavare. Riktlinjerna inneb&auml;r huvudsakligen att ledande befattningshavare ska erbjudas en marknadsm&auml;ssig kompensation, som ska beakta den enskildes ansvarsomr&aring;den och erfarenhet. Ers&auml;ttningen ska best&aring; av fast l&ouml;n och pension, med syfte att fr&auml;mja Bolagets l&aring;ngsiktiga v&auml;rdeskapande.<\/p>\n<p><strong>Instruktion f&ouml;r valberedningens arbete<\/strong><\/p>\n<p>I enlighet med styrelsens f&ouml;rslag beslutade st&auml;mman att den instruktion f&ouml;r valberedningens arbete som fastst&auml;lldes vid extra bolagsst&auml;mma den 30 november 2016 ska g&auml;lla of&ouml;r&auml;ndrad tillsvidare.<\/p>\n<p>Nicholas Waters, VD<\/p>\n<p>16 maj 2017<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB Therapeutics AB:s \u00e5rsst\u00e4mma 2017 avh\u00f6lls idag tisdagen den 16 maj p\u00e5 Wallenberg konferenscenter i G\u00f6teborg. Vid \u00e5rsst\u00e4mman fattades f\u00f6ljande huvudsakliga beslut.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-2772","post","type-post","status-publish","format-standard","hentry","category-pressmeddelande-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB - Beslut vid \u00e5rsst\u00e4mma 2017 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB - Beslut vid \u00e5rsst\u00e4mma 2017 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB Therapeutics AB:s \u00e5rsst\u00e4mma 2017 avh\u00f6lls idag tisdagen den 16 maj p\u00e5 Wallenberg konferenscenter i G\u00f6teborg. Vid \u00e5rsst\u00e4mman fattades f\u00f6ljande huvudsakliga beslut.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-16T16:42:48+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"IRLAB &#8211; Beslut vid \u00e5rsst\u00e4mma 2017\",\"datePublished\":\"2017-05-16T16:42:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/\"},\"wordCount\":366,\"commentCount\":0,\"articleSection\":[\"Pressmeddelande\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/\",\"url\":\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/\",\"name\":\"IRLAB - Beslut vid \u00e5rsst\u00e4mma 2017 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2017-05-16T16:42:48+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IRLAB &#8211; Beslut vid \u00e5rsst\u00e4mma 2017\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB - Beslut vid \u00e5rsst\u00e4mma 2017 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB - Beslut vid \u00e5rsst\u00e4mma 2017 - IRLAB","og_description":"IRLAB Therapeutics AB:s \u00e5rsst\u00e4mma 2017 avh\u00f6lls idag tisdagen den 16 maj p\u00e5 Wallenberg konferenscenter i G\u00f6teborg. Vid \u00e5rsst\u00e4mman fattades f\u00f6ljande huvudsakliga beslut.","og_url":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/","og_site_name":"IRLAB","article_published_time":"2017-05-16T16:42:48+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/"},"author":{"name":"","@id":""},"headline":"IRLAB &#8211; Beslut vid \u00e5rsst\u00e4mma 2017","datePublished":"2017-05-16T16:42:48+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/"},"wordCount":366,"commentCount":0,"articleSection":["Pressmeddelande"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/","url":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/","name":"IRLAB - Beslut vid \u00e5rsst\u00e4mma 2017 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2017-05-16T16:42:48+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/irlab-beslut-vid-arsstamma-2017\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"IRLAB &#8211; Beslut vid \u00e5rsst\u00e4mma 2017"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/2772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=2772"}],"version-history":[{"count":0,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/2772\/revisions"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=2772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=2772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=2772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}